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Cell Proliferation Not Associated with
Carcinogenesis in Rodents and Humans
by Jerrold M. Ward1, Hiroshi Uno2, Yasushi Kurata3,
Christopher M. Weghorst1, and Ja-June Jang4
Cell proliferation has often been found to be associated with carcinogenesis in rodents and
humans at different stages of the multistage carcinogenesis process. The multistage process
includes initiation, promotion, and progression phases. At each phase, increasing the normal
level ofcell turnover oftarget cells may enhance carcinogenesis. However, we present evidence
that normal levels of cell turnover, or increasing the rate of cell turnover at these different
stages, do not necessarily lead to enhanced carcinogenesis. In normal tissues, the length of the
cell cycle depends on the age of the host and varies from tissue to tissue. Tissues with normal
short cell cycles, such as intestine and bone marrow, do not show a high rate of spontaneous
tumors in most species. Cells with higher turnover should be more susceptible to carcinogens at
the initiation stage ofcarcinogenesis ifcell proliferation per se causes cancer and if these cells
or their progeny survive. Cancer in humans is more often associated with specific etiological
factors rather than with the natural proliferative rate of specific tissues. For many tissues of
humans and rodents, age-related diseases develop in a progressive, irreversible manner. Often,
naturally occurring chronic degenerative and inflammatory changes in a tissue (e.g., kidney,
liver, heart, reproductive tract) lead to chronic regeneration of the damaged tissue. Yet, cancer
is rarely found in these tissues. In rodent carcinogenesis experiments, chronic toxic lesions,
accompanied by increases in normal levels of cell turnover, have sometimes been observed in
target organs of nongenotoxic carcinogens. More often, however, organ-specific nongenotoxic
toxins are not carcinogens. These toxins include compounds toxic for the liver, kidney, and
nasal cavity. In 19 inhalation bioassays conducted by the National Toxicology Program, 5/5
nasal carcinogens and 12/14 nasal noncarcinogens caused nasal lesions usually associated with
chronic cell proliferation. Although cell proliferation may contribute to multistage carcinogen-
esis, cell proliferation is not necessarily a tumor promoter or cocarcinogen.
Introduction
Much information accumulated during the past 10
years reveals that cell proliferation (increased cell
turnover, hyperplasia) is often associated with carcino-
genesis in rodents and humans (1-7). Cell proliferation
may contribute to carcinogenesis at stages ofinitiation,
promotion, or progression (8). It has been postulated
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that cell proliferation can increase mutation rates or
help fix spontaneous or induced mutations (1,2). With
special pathology techniques, the labeling index (LI),
determined by tritiated thymidine autoradiography or
bromodeoxyuridine (BrdU) immunohistochemistry (9),
is used as a crude estimate ofthe numbers of cells in S
phase in tissues (10). Chemicals that have been found
not to possess genotoxic activities or that are weak
genotoxins sometimes cause tumors in rodent tissues,
with chronic histological lesions of toxicity often
indicative of cell proliferation. Similar situations may
exist for genotoxic chemicals. In some tissues, such as
mouse liver, chronic toxic lesions frequently accompa-
ny the hepatocarcinogenic or tumor-promoting activi-
ties of a chemical (11,12). As additional rodent bioas-
says are completed, recent information has become
available that many organ-specific toxins are not car-
cinogens (13-16).
This paper reviews some of these studies and
addresses important questions relevant to these
issues. We do not review or discuss the many associa-WARD ETAL.
tions of cancer and cell proliferation reported in
humans and rodents (4,5). Our review is limited by the
type of information available. Many studies have no
cell proliferation data available. A state of chronic cell
proliferation is suggested when chronic lesions, includ-
ing inflammation, epithelial hyperplasia, metaplasia,
and other lesions, are reported. When available, cell
proliferation data never contain cell cycle information.
We assume that the LI shows true cell turnover rates.
Sometimes, the nontarget cells are measured, and
often transient increases in cell proliferation are seen
rather than a sustained (persistent) increase. Little
information is reported on the association of the level
of induced cell proliferation and the level of the car-
cinogenic response. Should a 2-fold sustained increase
in LI produce a 2-fold increase in tumor incidence or
multiplicity? Also, the stage ofcarcinogenesis involved
(initiation, promotion, or progression) is not usually
determined for these effects. Much of the available
information is suggestive but not conclusive of the
stage ofcarcinogenesis affected.
Cell Turnover in Normal Tissues and
Natural Cancer
The length of the cell cycle varies with tissue, cell
type, age, and other factors (17). Adult tissues and
cells with the shortest cell cycle times include the
small intestine (10 hr in mice and rats), lymphoid ger-
minative cells (germinal centers), and bone marrow. A
comparison of cell cycle times and tumor incidence in
humans (18) and rodents shows that there is no gener-
al correlation between cell cycle time and tumor inci-
dence (Fig. 1). In humans, etiological factors (viruses,
genetic, or environmental factors) appear to be more
important. Although colon epithelial cell-cycle times
are short (25 hr in humans), low incidences of colon
carcinoma are found in some populations (Japan),
whereas high incidences are seen in others (United
States). Mouse leukemia of lymphocyte origin, from
cells with low cell-cycle times, occur at high incidences
in some mouse strains but at very low incidences in
many other strains. Evidently, the length of the cell
cycle may be associated with carcinogenesis in some
organs only or else other factors are involved (8).
It has been suggested that small intestinal (duode-
nal) proliferative cells migrate toward the tip of the
villus and are sloughed into the gut lumen (1,2). This
phenomenon may explain why the duodenum has low
cancer rates despite low cell-cycle times. However,
duodenal stem cells also have low cell-cycle times (at
25 hr) (17), do not migrate, and remain in the epitheli-
um (Fig. 2), where they may be exposed to carcinogens
and potential DNA damage.
Humans and animals that are larger (taller or heav-
ier) than normal may develop cancer at higher rates
than smaller humans and animals (19-21). The size ofa
specific cell type in an organ of each species should be
identical in males and females, although there may be
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FIGURE 1. An estimate of cell-cycle time and tumor incidence for
selected tissues ofhumans, rats, and mice. Human data from Ries
et al. (18).
FIGURE 2. Duodenum of mouse that was exposed to a minipump con-
taining BrdU for 48 hr and then 24 hr without the pump. Large
cells are putative stem cells (antigen-retaining cells, slow-cycling
cells) with abundant BrdU (arrows), while proliferating cells
(arrowheads) have migrated and divided within 24 hr and have
less nuclear BrdU. BrdU immnohistochemistry, 400X.
species differences. Thus, organs of larger humans or
animals should have more cells to account forincreased
body and organ size. Ifa man weighs twice as much as
another man (assuming similar body-fat mass), he may
have twice as many cells in his body as the smaller
man. If normal cell cycles and spontaneous mutation
rates are similar for each cell in a specific tissue, then
more spontaneous mutations should occur in a larger
organ. Ifthese rates were associated with spontaneous
cancer (1,2), more cancer should be found in larger ani-
mals and people. Yet, the latter situation does not
occur for most tissues. Some differences in humans of
larger stature were reported forincidences ofmale col-
orectal cancer and a few other sites but not for most
tissues, especially in females (20,21).
Cell Proliferation in Natural Diseases
Many tissues of animals and humans develop age-
related degenerative lesions. These changes occur
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FIGURE 3. A sequence of cellular events after degenerative diseases
induced by endogenous or exogenous agents.
from exposure to endogenous and exogenous sub-
stances and from genetically programmed processes.
Damaged cells and tissues attempt to repair the
degenerative processes through regeneration of the
affected cells (Fig. 3). This process of damage and
repair is continuous throughout life and is common in
the kidney (22), liver, heart, skin, and reproductive tis-
sues of many species (23). Repair is evidenced by the
presence of hyperplastic basophilic cells in epithelial
tissues, increased LI (10,12,22), and increased frequen-
cy of mitotic cells. Tumors may develop in these tis-
sues in older individuals but often occur at low inci-
dence (24).
Rats
Aging nephropathy (chronic progressive nephrosis)
is often associated with regenerative renal cortical
tubules in rats (22,24). Increased levels of cell prolifer-
ation are often seen in these regenerative tubules
(22,25), yet spontaneous renal tubular cell tumors are
uncommon [less than 1% incidence in rats (24)].
Interestingly, the levels of cell proliferation found in
cortical tubules of aging nephropathy are similar to
those induced by nongenotoxic renal carcinogens, such
as unleaded gasoline (25). Renal tumors induced by
these nongenotoxic renal toxins and carcinogens usual-
ly occur at rates greater than 20% (26). Bile duct
hyperplasia is seen in most aged F344 rats, but tumors
of these cells are extremely rare (22). Focal hyperpla-
sia ofhepatocytes (basophilic foci) is often observed in
aging F344 rats, with little evidence of spontaneous
tumorigenesis (24,27).
Humans
In humans, many chronic conditions are associated
with regenerative hyperplasia or chronic hyperplasia
without evidence of increased risk from cancer. These
conditions can involve almost any tissue. Enlargement
of the male breast (gynecomastia) may occur in
response to excess estrogen (23). Gynecomastia is one
FIGURE 4. Gynecomastia in male breast showing increased branching
and cell layering ofducts. H&E, lOOX.
manifestation of Klinefelter's syndrome and may occur
in patients with functioning testicular neoplasms such
as Leydig cell and, rarely, Sertoli cell tumors.
Gynecomastia may occur any time during adult life
when there is cause for hyperestrinism. The most
important cause of hyperestrinism in the male is cir-
rhosis of the liver, since the liver is responsible for
metabolizing estrogen. Gynecomastia also may be seen
in chronic marijuana smokers and heroin addicts.
Microscopically, there is marked hyperplasia of the
ductal linings with piling up ofmultilayered epithelium
(Fig. 4). Gynecomastia does not appear to increase the
risk ofmale breast cancer (28,29).
Non-neoplastic nodular enlargement of the prostate
(nodular hyperplasia, benign prostatic hypertrophy or
hyperplasia) is the most common symptomatic tumor-
like condition in humans. Studies have shown that
nodular hyperplasia originates almost exclusively in
the inner periurethral portion ofthe classically defined
middle and lateral lobes (30). This distribution is in
striking contrast to that of the prostatic carcinoma,
which usually involves the posterior lobe. Micro-
scopically, the nodularity may be due mainly to glandu-
lar proliferation or dilatation or to fibrous or muscular
proliferation ofthe fibromuscular stroma. The epitheli-
um is characteristically organized into many papillary
buds and infoldings, which are more prominent than in
the normal prostate (Fig. 5). Nodular hyperplasia of
the prostate has been suggested as a cancer precursor,
but most experts do not believe that this benign lesion
has any relationship to the development of cancer (31).
Peptic ulcers are chronic, most often solitary, lesions
that occur at any level of the gastrointestinal tract
exposed to the aggressive action of acid-peptic juices.
(23). Adjacent to the ulcer there is chronic inflamma-
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FIGURE 5. Prostatic hyperplasia reveals increased folding and num-
bers ofepithelial cell layers. H&E, lOOx.
tion and epithelial hyperplasia (Fig 6). Approximately
98-99% of peptic ulcers occur in either the duodenum
or the stomach in a ratio ofabout 4:1. About 10-20% of
patients with a gastric ulcer have concurrent duodenal
lesions. In contrast to the stomach and colon, carcino-
mas are rare in the small intestine (18), despite the
enormous surface area ofthe epithelium at risk and its
constant replicative activity. Malignant transformation
is unknown with duodenal ulcers but has been reported
with gastric lesions (23). More likely, the "ulcer" was
malignant from the outset. Cancers ulcerate, but ulcers
rarely become cancerous (23). It is extremely difficult
to establish the occurrence of a sequence of events in
any particular case. Gastric cancer may arise in associa-
tion with other types ofproliferative lesions (4,23).
Psoriasis is an inflammatory and epidermal hyper-
proliferative disease of the skin (32). Ki-67 immunore-
activity, BrdU exposure in vitro, and immunohisto-
chemistry were used to evaluate rates ofcell proliferation
in epidermis ofnormal and psoriatic subjects. Patients
with psoriasis had greatly increased numbers of
labeled cells in the basal layer (some ofwhich are prob-
ably stem cells) and other layers ofthe epidermis (32).
Yet, epidemiological studies have not found an
increased risk for skin tumors in these patients (33).
However, after therapy with psoralens and ultraviolet
A irradiation (PUVA) and ultraviolet B radiation, an
increased risk of genital skin tumors was seen (34).
Although the hyperproliferative state of psoriasis
alone does not lead to cancer, it may serve as an impor-
tant cofactor with PUVA therapy.
B
FIGURE 6. (A) Region of peptic ulcer showing inflammation and
hyperplastic epithelium (dark glands). H&E lOOX. (B) Prolifer-
ating cell nuclear antigen immunohistochemistry showing nuclear
staining ofproliferating cells. H&E, lOOX.
A
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Induced Cell Proliferation and
Tumors in Rodents
There is an increasing volume of information that
shows chemically induced chronic toxicity, with histo-
logical evidence ofepithelial regeneration (cell prolifer-
ation, hyperplasia) and with or without cell prolifera-
tion data (tritiated thymidine autoradiography and
BrdU or proliferating cell nuclear antigen [PCNA]
immunohistochemistry) is not associated with carcino-
genesis in rodents (9-11,14-16,35,36). This phenome-
non may be more common than are experiments with
associations of chronic toxicity, cell proliferation, and
carcinogenesis.
Nasal Carcinogenesis
Nasal carcinogenesis is often induced by potent
genotoxic chemicals, especially specific genotoxic
nitrosamines (36,38). Some nongenotoxic or weakly
genotoxic nasal carcinogens have induced such tumors
accompanied by inflammatory and hyperplastic epithe-
lial lesions. Formaldehyde-induced nasal carcinomas
and hyperplastic lesions are seen with increased levels
of cell proliferation in rats (39,40). More recently, bio-
assays sponsored by the National Toxicology Program
(NTP) (41-44) have provided information on inhalation
studies with 10 chemicals in rats and mice (Tables 1-3).
Five chemicals were found to be nasal carcinogens, and
14 chemicals were not carcinogenic for the nasal cavity
(Tables 1-4). Of the 5 carcinogens, all induced inflam-
matory and proliferative (regenerative) nasal lesions.
Ofthe 14 noncarcinogens, 12 induced similar inflamma-
tory and proliferative nasal lesions. Of the 5 carcino-
gens, 3 also caused tumors at other sites, and 7 of the
14 nasal noncarcinogens caused other tumors. By
Table 1. Inhalation bioassays of 19 chemicals from NTP Technical Reports (13,37).
No. with
No. of No. No. with epithelial No. with
chemicals mutagenic nasal lesionsa hyperplasia metaplasia
Nasal carcinogens 5 5 5 5 4
Nasal noncarcinogens 14 6 12 8 8
aLesions include inflammation ofvarious types, epithelial hyperplasia, squamous metaplasia, and metaplasia.
Table 2. Nasal lesions reported in 74 NTP inhalation experiments from 19 NTP Technical Reports.
No. with
No. of No. with epithelial No. with
groups nasal lesions hyperplasia metaplasia
Nasal carcinogens 15 15 13 11
Nasal noncarcinogens 57h 36 26 23
aLesions include inflammation ofvarious types, epithelial hyperplasia, squamous metaplasia, and metaplasia.
bIncludes five sex/species groups given chemicals inducing nasal tumors in other sex/species groups.
Table 3. Five NTP nasal carcinogens inducing nasal lesions, including epithelial hyperplasia and metaplasia (13).a
NTP Technical Nasal Nasal Epithelial
Chemical Report number Species Sex tumors lesions hyperplasia Metaplasia
Allyl glycidyl ether 376 Rats Male + + + +
Rats Female - + + +
Mice Male + + + +
Mice Female - + + +
1,2-Dibromo-3-chloropropane 206 Rats Male + + +
Rats Female + + +
Mice Male + + +
Mice Female + + +
1,2-Dibromoethane 210 Rats Male + + + +
Rats Female + + + +
Mice Male + + + +
Mice Female + + + +
1,2-Epoxybutane (lung) 329 Rats Male + + + +
Rats Female - + + +
Mice Male - + + +
Mice Female - + + +
Propylene oxide 267 Rats Male + + + +
Rats Female + + + +
Mice Male + + - +
Mice Female + + - +
a+, present; -, not reported.
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species/sex experiments, 15/15 ofthe experiments with
the nasal carcinogens induced nasal lesions, and 36/59
experiments with the nasal noncarcinogens induced
nasal lesions (Table 2). Often, a whole spectrum of
lesions was seen, similar to those lesions described for
formaldehyde (39).
Recently, in a detailed 6-week inhalation experiment
with formaldehyde, the L3 segment of the rat nasal
cavity was found to have the highest level ofpersistent
epithelial cell proliferation, although tumors rarely
developed in this region (45). Inhalation of1,3-dichloro-
propene produced nasal erosions and fibrosis with
hyperplasialhypertrophy in mice but no hyperplasia in
rats, although these types oflesions are often associat-
ed with hyperplasia (46).
Liver
Chronic toxicity has also been implicated as the dri-
ving force behind the carcinogenic potential of some
chemicals (especially the nongenotoxic carcinogens) in
the liver, via the indirect stimulation of chronic com-
pensatory cell proliferation with "higher dosages"
(1,2,7,10). However, several inconsistencies have been
reported in the literature (47). Recently, a retrospec-
tive evaluation of the NTP's carcinogenesis database
revealed that only 25% ofthe F344 rat bioassays eval-
uated exhibited a positive correlation between chemi-
cally induced toxicity and increased liver tumor occur-
rence (14). In the B6C3Fj mouse studies, a positive
correlation occurred in only 51% of the studies
assessed. Studies conducted in our laboratory revealed
similar noncorrelative results. Chronic administration
of acetaminophen to B6C3Fj mice resulted in severe
liver toxicity; however, no increases in tumor incidence
were noted (9,48). It must be noted that in those stud-
ies, only limited cell proliferation data were sometimes
available, and therefore we can only deduce that there
is, at most, a small correlation between chemically
induced toxicity and hepatic carcinogenesis.
Inconsistencies in correlating the induction of cell
proliferation by a chemical with its known or potential
tumorigenic capabilities have also been identified in
the liver (47). An example of a positive correlation
between the two was reported by Cunningham et al.
(12) using two isomers of diaminotoluene (DAT). The
compounds 2,4-DAT and 2,6-DAT are equally absorbed,
metabolized, and excreted and are genotoxically
active. However, only 2,4-DAT produced liver tumors
in chronic rodent bioassays. When similar doses of
each compound were evaluated over a 9-day period for
their effects on hepatic cell proliferation, 2,4-DAT pro-
duced a dose-dependent increase in DNA synthesis,
whereas 2,6-DAT had no effect. It is not known ifthis
proliferative response is sustained. In contrast to these
reports, other investigators have reported studies in
which no such correlations can be made. Chronic expo-
sure of B6C3Fj mice to unleaded gasoline vapors
increased liver tumorigenesis in female B6C3Fj mice
but not in male mice. In contrast, when DNA synthesis
was evaluated, a 6- to 10-fold increase in the LI was
found in the livers of both female and male mice (49).
Sex specificity for tumorigenicity and cell proliferation
induced by 1,4-dichlorobenzene was not seen (50).
Di(2-ethylhexyl)phthalate) (DEHP) is a plasticizer,
rodent hepatocarcinogen, and hepatotoxin (51). As a
peroxisomal proliferator, DEHP causes severe liver
enlargement (more than twice normal) and persistent
(sustained), dose-related increase in the hepatocyte LI
[more than 10 times normal at the highest dose (9)]. In
the original NTP bioassay, hepatocellular adenomas or
carcinomas were found in 14/50 (28%) of the control
males, 25/48 (52%) of the low-dose males (3000 ppm),
and 29/50 (58%) ofthe high-dose (6000 ppm) males (52).
Thus, tumors were found in twice as many low-dose
and high-dose males as in controls. In a 40-week toxici-
ty study, we found doses of6000 ppm caused a 1- to 3-
fold increase in hepatocyte LI (9). These findings sug-
gest a persistent LI at the level ofthe tumor increase.
In a recent 91-week study, we found that although the
persistent hepatocyte LI ofmice given 12,000 ppm was
10- to 15-fold over normal, the tumor incidence was
only 3- to 5-fold over normal (J. M. Ward and H. Uno,
unpublished data). The numbers of preneoplastic foci
per liver, however, were more closely correlated with
LI. Also, the tumor incidence in mice receiving 6,000
ppm was similar to that in mice at 12,000 ppm despite a
2- to 10-fold difference in LI. It was recently reported
that cell proliferation by the carcinogenic peroxisomal
proliferators, clofibric acid and nafenopin, was not sus-
tained beyond 4 weeks (53). Additional studies should
help clarify the quantitative relationships, if any,
between dose, LI, and tumor incidence.
Skin
Tumor promotion in mouse skin is usually associated
with epidermal hyperplasia (10,54). Most skin irritants
are tumor promoters in mouse epidermis, except tur-
pentine (54). In skin tumor-promotion assays and in a
short-term assay for hyperplasia, turpentine did not
possess promoting activity but did cause epidermal
hyperplasia (Fig. 7). the level of cell proliferation was
similar to that of ethylphenylpropiolate, a tumor pro-
moter (54).
Kidney
Unleaded gasoline and 2,2,4-trimethylpentane caused
a2u-globulin accumulation in the P2 segment of the
proximal renal tubules, persistent increases in the LI
of the P2 segment, and renal tumors in this segment
(25,26). The P3 segment, however, also had high per-
sistent levels of cell proliferation without evidence of
renal carcinogenesis (25). Although several compounds
classified as chemicals inducing a2u-globulin accumula-
tion (CIGAs) have induced renal tumors and apparent
renal tubular hyperplasia, rats administered gaba-
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Table 4. Fourteen NTP nasal non-carcinogens inducing nasal lesions including epithelial hyperplasia
and metaplasia (13).a
NTP Technical Nasal
Chemical Report number Species Sex lesions
Bromoethane 363 Rats
1,3-Butadiene
2-Chloroacetophenone
a-Chlorobenzyalmalonitrile
Chloroethane
Dichloromethane
1-epinephrine HCL
Ethylene oxide
Methyl methacrylate
Propylene
Tetrachloroethylene
Tetranitromethane
Toluene
Vinyltoluene (mixed isomers)
288
379
377
346
306
380
326
314
272
311
386
371
375
a+, present; -, not reported.
Rats
Mice
Mice
Mice
Mice
Rats
Rats
Mice
Mice
Rats
Rats
Mice
Mice
Rats
Rats
Mice
Mice
Rats
Rats
Mice
Mice
Rats
Rats
Mice
Mice
Mice
Mice
Rats
Rats
Mice
Mice
Rats
Rats
Mice
Mice
Rats
Rats
Mice
Mice
Rats
Rats
Mice
Mice
Rats
Rats
Mice
Mice
Rats
Rats
Mice
Mice
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
Male
Female
pentin did not develop renal tumors despite the induc-
tion ofrenal hyaline droplets and renal tubular hyper-
plasia (55). DEHP, a renal toxin in B6C3F1 mice, pro-
duced sustained increases in LI of renal tubules but
was not a renal carcinogen or tumor promoter (35).
Streptozotocin initiation inhibited the nephropathy
and cell proliferation induced by barbital sodium but
failed to inhibit the tumor-promoting effects ofthe bar-
bital sodium (36). Mercuric chloride produced a chemi-
cally related increase in nephropathy and parathyroid
hyperplasia (Fig. 8) in rats but no renal tumors in a
recent NTP bioassay (56). Four other renal toxins
were not carcinogenic in 2-year bioassays (15).
Diphenyl induced renal pelvic stones, obstructive
pyelonephritis, renal tubular atrophy, cystic tubules,
and fibrosis (57), lesions usually associated with
increases of cell proliferation in renal tubules. When
diphenyl was studied for renal tumor-promoting activi-
Metaplasia
+
+
Epithelial
hyperplasia
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
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Other Tissues
A lack of correlation between organ-specific chronic
toxicity and carcinogenesis was shown in a review of
NTP bioassays, although data on cell proliferation
_ ,_ ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ 5 ._ _ W .41 .. - ..L... ..
FIGURE 7. Mouse skin 48 hr after application of turpentine. A high
labeling index is seen in basal areas. BrdU immunohistochem-
istry, hematoxylin, 250X.
5.0 r
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ty after initiation by N-ethyl-N-hydroxyethylnitro-
samine, it possessed no tumor-promoting activity for
kidney tubules (57). Renal pelvic hyperplasia was
induced in male rats by d-limonene but no pelvic
tumors were found (58).
Urinary Bladder
Hyperplasia ofthe urothelium has been suggested to
play an important role in bladder carcinogenesis and
tumor promotion (3-5). Yet, examples can be found
that suggest hyperplasia is not associated with car-
cinogenesis in these instances. Hyperplasia of the uri-
nary bladder induced in mice by 1,3-dichloropropene
was not significantly associated with any bladder
tumors (46). Melamine caused bladder stones and
epithelial hyperplasia in rats and mice, yet bladder
tumors were only found in rats (59). Papillary-nodular
bladder hyperplasia, type A, did not develop into papil-
loma, but type-B hyperplasia progressed to papilloma
(60). Butylated hydroxytoluene (BHA) induced a high
level ofpersistent increases in bladder epithelial DNA
synthesis (Fig. 9), and sodium L-ascorbate produced a
5-fold lower level increase of DNA synthesis (61). Yet,
sodium L-ascorbate promoted bladder hyperplasias,
papillomas, and carcinomas to a similar degree as did
BHA (62-64). BHA was not carcinogenic for the rat
urinary bladder in long-term studies (65,66).
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FIGURE 8. Incidence of renal tumors, nephropathy, and parathyroid
hyperplasia in rats exposed to mercuric chloride, a classical acute
nephrotoxin (56).
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FIGURE 9. (A) Labeling index of urinary bladder epithelium of rats
after exposure to chemicals and minipump containing BrdU (61).
(B) Incidence ofurinary bladder lesions of rats after tumor initia-
tion by BBN and subsequent exposure to sodium ascorbate, ascor-
bic acid, or butylated hydroxyanisole (62-64).
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were not available (14,15). These reviews involved
many tissues. Besides the tissues noted above, we
occasionally found published reports that showed his-
tological evidence of chronic toxicity and/or hyperpla-
sia without carcinogenesis. Although forestomach
hyperplasia was associated with carcinogenesis in male
and female rats gavaged with 3-chloro-2-methyl-
propene, low dose female rats had basal cell hyperpla-
sia at an incidence of 84% without evidence of carcino-
genesis (67). Four other chemicals caused forestomach
hyperplasia without evidence of carcinogenesis (15).
Gastric and duodenal ulcers induced by freeze ulcera-
tion increased cancer incidence induced by a nitro-
samine in the gastric fundus and proximal duodenum,
but not in the other parts of the duodenum, pylorus,
or forestomach (68). An interesting phenomenon has
been described in amphibia exposed to carcinogens.
Forelimb blastemas, generated after limb amputation,
have marked levels of regeneration, yet are resistent
to carcinogenesis by potent carcinogens (69).
Summary and Conclusions
Cell proliferation has often been associated with car-
cinogenesis in specific tissues of humans and rodents
(4-6). However, an increasing number ofexamples can
be found that suggest cell proliferation is often not
associated with carcinogenesis (9,14,16,35,45,47,49,50).
In this review, we presented some examples of cell
proliferation without carcinogenesis. Many other cases
can be found. If chronic cell proliferation occurs but is
not associated with an increased risk for carcinogene-
sis, several possible hypotheses may be considered. If
one assumes that cell proliferation should increase can-
cer risk in most cases (4,5), the lack of carcinogenesis
in some situations mnay occur for the following reasons.
Cell proliferation may occur without involvement of
stem cells, which are important targets of carcinogens
(4,5). Often, increases in the compartment of prolifer-
ating cells are responsible for cell proliferation in a
tissue. Stem cells should be involved in the prolifera-
tive process (5) but may not be the only targets of car-
cinogens (70). Preneoplastic cells and foci occurring
naturally or induced, may also be targets of carcino-
gens or tumor promoters. Iftransient or sustained cell
proliferation occur before the appearance of these
lesions, the maximal effect of cell proliferation will be
minimized. The effect of cell proliferation should be
dose related, but limited evidence suggests otherwise
(9,10,15). One might expect a dose-related increase of
the level of cell proliferation and carcinogenesis if the
two phenomena were entirely related.
Finally, cell proliferation may not play a role in car-
cinogenesis in specific cases only or in all cases in
which it is found. Cell proliferation may be a red her-
ring in the multistage carcinogenesis process. There is
evidence that some mutations may be time dependent
instead of replication dependent (71). Research on the
role of spontaneous mutations in carcinogenesis by
nongenotoxic and genotoxic carcinogens should pro-
vide some important information on the role of cell
proliferation in carcinogenesis.
We are grateful for the aid of John Henneman, Deborah Devor,
Miriam Anver, Shirley Hale, Mary Milner, Barbara Kasprzak, and
Kenneth Chu.
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